000 01486 a2200421 4500
005 20250515011235.0
264 0 _c20060622
008 200606s 0 0 eng d
022 _a1538-4047
024 7 _a10.4161/cbt.5.2.2334
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRamos, Tania Crombet
245 0 0 _aTreatment of NSCLC patients with an EGF-based cancer vaccine: report of a Phase I trial.
_h[electronic resource]
260 _bCancer biology & therapy
_cFeb 2006
300 _a145-9 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
650 0 4 _aAged
650 0 4 _aAntibodies
_xblood
650 0 4 _aCancer Vaccines
_xadverse effects
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xtherapy
650 0 4 _aEpidermal Growth Factor
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Active
650 0 4 _aLung Neoplasms
_xtherapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aVinageras, Elia Neninger
700 1 _aFerrer, Mauricio Catalá
700 1 _aVerdecia, Beatriz García
700 1 _aRupalé, Idrissa Leonard
700 1 _aPérez, Liana Martínez
700 1 _aMarinello, Gisela González
700 1 _aRodríguez, Rolando Pérez
700 1 _aDávila, Agustín Lage
773 0 _tCancer biology & therapy
_gvol. 5
_gno. 2
_gp. 145-9
856 4 0 _uhttps://doi.org/10.4161/cbt.5.2.2334
_zAvailable from publisher's website
999 _c15977724
_d15977724